Marcia L. Moss
Verve Therapeutics (United States)(US)
Publications by Year
Research Areas
Peptidase Inhibition and Analysis, Protease and Inhibitor Mechanisms, Signaling Pathways in Disease, Cell Adhesion Molecules Research, HER2/EGFR in Cancer Research
Most-Cited Works
- → Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α(1997)1,616 cited
- → Metalloprotease-Disintegrin MDC9: Intracellular Maturation and Catalytic Activity(1999)315 cited
- → Endotoxin induces rapid metalloproteinase-mediated shedding followed by up-regulation of the monocyte hemoglobin scavenger receptor CD163(2002)208 cited
- → The Τumor Necrosis Factor-α Converting Enzyme (TACE): A Unique Metalloproteinase with Highly Defined Substrate Selectivity(2002)199 cited
- → Drug Insight: tumor necrosis factor-converting enzyme as a pharmaceutical target for rheumatoid arthritis(2008)197 cited
- → Species Specificity of ADAM10 and ADAM17 Proteins in Interleukin-6 (IL-6) Trans-signaling and Novel Role of ADAM10 in Inducible IL-6 Receptor Shedding(2011)195 cited